SBIR Solutions to Enable Population Genomic Screening (R43/R44 Clinical Trial Optional)

The purpose of this notice of funding opportunity (NOFO) is to solicit Small Business Innovation Research (SBIR) grant applications from small businesses to develop innovative solutions for commercialization that would enable population screening for common, actionable genomic conditions in a primary


care setting.
Related Programs

Human Genome Research

Department of Health and Human Services


Agency: Department of Health and Human Services

Office: National Institutes of Health

Estimated Funding: $2,028,125


Who's Eligible



Obtain Full Opportunity Text:
https://grants.nih.gov/grants/guide/pa-files/PAR-24-263.html

Additional Information of Eligibility:
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.

Non-domestic (non-U.S.) components of U. S. Organizations are not eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.

Full Opportunity Web Address:
http://grants.nih.gov/grants/guide/pa-files/PAR-24-263.html

Contact:


Agency Email Description:
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.

Agency Email:


Date Posted:
2024-08-16

Application Due Date:


Archive Date:
2025-01-07


Meticulon, a project of Autism Calgary Association in partnership with the federal government and the Sinneave Family Foundation, operates as a social enterprise that renders high-tech services provided by people with autism, leveraging their natural abilities at requiring attention to detail, repetition, and sequencing.






More Federal Domestic Assistance Programs


Central Valley Project Improvement Act, Title XXXIV | Minority Business Enterprise Centers | Helium Resource Management | National Center for Missing and Exploited Children (NCMEC) | Specialty Crop Block Grant Program |  Site Style by YAML | Grants.gov | Grants | Grants News | Sitemap | Privacy Policy


Edited by: Michael Saunders

© 2004-2024 Copyright Michael Saunders